STELLAR-304: A randomized phase III study of zanzalintinib (XL092) and nivolumab in non-clear cell renal cell carcinoma (nccRCC) Meeting Abstract
| Authors: | Pal, S. K.; Powles, T. B.; Kanesvaran, R.; Lee, C. H.; Liu, M.; Wang, Z.; Bhatt, A.; Patel, P.; Suarez Rodriguez, C. |
| Abstract Title: | STELLAR-304: A randomized phase III study of zanzalintinib (XL092) and nivolumab in non-clear cell renal cell carcinoma (nccRCC) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S1028 |
| End Page: | S1029 |
| Language: | English |
| ACCESSION: | WOS:001087480202576 |
| DOI: | 10.1016/j.annonc.2023.09.2854 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1912TiP -- Source: Wos |
